Unknown

Dataset Information

Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming.


ABSTRACT: An ideal malaria vaccine platform should potently induce protective immune responses and block parasite transmission from mosquito to human, and it should maintain these effects for an extended period. Here, we have focused on vaccine development based on adeno-associated virus serotype 1 (AAV1), a viral vector widely studied in the field of clinical gene therapy that is able to induce long-term transgene expression without causing toxicity in vivo. Our results show the potential utility of AAV1 vectors as an extremely potent booster vaccine to induce durable immunity when combined with an adenovirus-priming vaccine in a rodent malaria model. We generated a series of recombinant AAV1s and human adenovirus type 5 (AdHu5) expressing either Plasmodium falciparum circumsporozoite

SUBMITTER: Yusuf Y 

PROVIDER: S-EPMC6460511 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature